Maternal hormonal contraceptive use and offspring overweight or obesity

被引:6
作者
Jensen, E. T. [1 ,2 ]
Daniels, J. L. [2 ]
Stuermer, T. [2 ]
Robinson, W. R. [2 ]
Williams, C. J. [1 ]
Moster, D. [3 ]
Juliusson, P. B. [4 ]
Vejrup, K. [5 ]
Magnus, P. [5 ]
Longnecker, M. P. [1 ]
机构
[1] Natl Inst Environm Hlth Sci, Dept Epidemiol, NIH, Res Triangle Pk, NC 27709 USA
[2] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
[3] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway
[4] Univ Bergen, Dept Clin Sci, Bergen, Norway
[5] Natl Inst Publ Hlth, Div Epidemiol, Oslo, Norway
基金
美国国家卫生研究院;
关键词
ORAL-CONTRACEPTIVES; BIRTH-WEIGHT; RISK-FACTORS; EXPOSURE; METABOLISM; PREGNANCY; CHILDHOOD; SEX; PROGESTERONE; PREVALENCE;
D O I
10.1038/ijo.2014.114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND/OBJECTIVES: Experiments in animal models have shown a positive association between in utero exposure to pharmacologic sex hormones and offspring obesity. The developmental effects of such hormones on human obesity are unknown. SUBJECTS/METHODS: Using data from a large, prospective pregnancy cohort study (n = 19 652), with linkage to a national prescription registry, we evaluated the association between use of hormonal contraceptives before and after conception (defined from dispensed prescription data and characterized by last date of use relative to conception, 12 to >4 months before (n = 3392), 4 to >1 months before (n = 2541), 1 to >0 months before (n = 2997) and 0-12 weeks after (n = 567)) in relation to offspring overweight or obesity at age 3 years. RESULTS: We observed a weak, inverse association between early pregnancy use of a combination oral contraceptive and offspring overweight or obesity at age 3 (adjusted odds ratio (OR): 0.75, 95% confidence interval (CI): 0.53, 1.08) and a positive, but imprecise, association with use of a progestin-only oral contraceptive in early pregnancy (adjusted OR: 1.26, 95% CI: 0.79, 2.02). In general, no association was observed between the use of a hormonal contraceptive before conception and offspring overweight or obesity. A sensitivity analysis comparing combination oral contraceptive users in early pregnancy to other unplanned pregnancies without hormonal contraceptive use further strengthened the inverse association (adjusted OR: 0.70, 95% CI: 0.48, 1.02). Other sensitivity analyses were conducted to evaluate the robustness of the associations observed given varying assumptions. CONCLUSIONS: Pharmacologic sex hormones in early pregnancy may be inversely or positively associated with offspring overweight or obesity at age 3, depending on the specific formulation used. The present study provides support for the potential for environmental sources of hormonally active agents to exert developmental effects.
引用
收藏
页码:1275 / 1281
页数:7
相关论文
共 50 条
  • [41] The Risk of Offspring Psychiatric Disorders in the Setting of Maternal Obesity and Diabetes
    Kong, Linghua
    Norstedt, Gunnar
    Schalling, Martin
    Gissler, Mika
    Lavebratt, Catharina
    PEDIATRICS, 2018, 142 (03)
  • [42] Maternal obesity and long-term neuropsychiatric morbidity of the offspring
    Neuhaus, Zipora Feiga
    Gutvirtz, Gil
    Pariente, Gali
    Wainstock, Tamar
    Landau, Daniella
    Sheiner, Eyal
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (01) : 143 - 149
  • [43] Association of maternal psychological distress with children with overweight/obesity in Ethiopia
    Biadgilign, Sibhatu
    Mgutshini, Tennyson
    Deribew, Amare
    Gelaye, Bizu
    Memiah, Peter
    CHILD CARE HEALTH AND DEVELOPMENT, 2023, 49 (02) : 392 - 399
  • [44] Impact of maternal overweight and obesity on milk composition and infant growth
    Ellsworth, Lindsay
    Perng, Wei
    Harman, Emma
    Das, Arun
    Pennathur, Subramaniam
    Gregg, Brigid
    MATERNAL AND CHILD NUTRITION, 2020, 16 (03)
  • [45] Maternal Diabetes and Overweight and Congenital Heart Defects in Offspring
    Turunen, Riitta
    Pulakka, Anna
    Metsala, Johanna
    Vahlberg, Tero
    Ojala, Tiina
    Gissler, Mika
    Kajantie, Eero
    Helle, Emmi
    JAMA NETWORK OPEN, 2024, 7 (01) : E2350579
  • [46] Maternal Hypertriglyceridemia: A Link Between Maternal Overweight-Obesity and Macrosomia in Gestational Diabetes
    Olmos, Pablo R.
    Rigotti, Attilio
    Busso, Dolores
    Berkowitz, Loni
    Santos, Jose L.
    Borzone, Gisella R.
    Poblete, Jose A.
    Vera, Claudio
    Belmar, Cristian
    Goldenberg, Denisse
    Samith, Barbara
    Acosta, Ana M.
    Escalona, Manuel
    Niklitschek, Ian
    Mandiola, Jorge R.
    Mertens, Nicolas
    OBESITY, 2014, 22 (10) : 2156 - 2163
  • [47] Perinatal exposures and adolescence overweight: The role of shared maternal-offspring pathways
    Shapiro, Ilona
    Youssim, Iaroslav
    Paltiel, Ora
    Calderon-Margalit, Ronit
    Manor, Orly
    Friedlander, Yechiel
    Hochner, Hagit
    ATHEROSCLEROSIS, 2024, 389
  • [48] Impact of maternal obesity on offspring obesity and cardiometabolic disease risk
    Drake, Amanda J.
    Reynolds, Rebecca M.
    REPRODUCTION, 2010, 140 (03) : 387 - 398
  • [49] Joint Associations of Maternal Gestational Diabetes and Hypertensive Disorders of Pregnancy With Overweight in Offspring
    Gu, Yuying
    Lu, Jun
    Li, Weiqin
    Liu, Huikun
    Wang, Leishen
    Leng, Junhong
    Li, Wei
    Zhang, Shuang
    Wang, Shuting
    Tuomilehto, Jaakko
    Yu, Zhijie
    Yang, Xilin
    Baccarelli, Andrea A.
    Hou, Lifang
    Hu, Gang
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [50] Maternal Prepregnancy Overweight and Offspring Fatness and Blood Pressure: Role of Physical Activity
    Eisenman, Joey C.
    Sarzynski, Mark A.
    Tucker, Jerod
    Heelan, Kate A.
    PEDIATRIC EXERCISE SCIENCE, 2010, 22 (03) : 369 - 378